Pentagon contract could send this $2 AI stock soaring

Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...

Scott Pancoast Biography and Net Worth

Director of DermTech

Mr. Scott Pancoast is the Director of DermTech.

What is Scott R. Pancoast's net worth?: The estimated net worth of Scott R. Pancoast is at least $27,097.05 as of December 14th, 2020. Mr. Pancoast owns 44,132 shares of DermTech stock worth more than $27,097 as of April 24th. This net worth estimate does not reflect any other investments that Mr. Pancoast may own. Learn More about Scott R. Pancoast's net worth.
How do I contact Scott R. Pancoast?: The corporate mailing address for Mr. Pancoast and other DermTech executives is 11099 N. Torrey Pines Road Suite 100, La Jolla CA, 92037. DermTech can also be reached via phone at (858) 450-4222 and via email at [email protected]. Learn More on Scott R. Pancoast's contact information.
Has Scott R. Pancoast been buying or selling shares of DermTech?: Scott R. Pancoast has not been actively trading shares of DermTech in the last ninety days. Most recently, Scott R. Pancoast sold 5,000 shares of the business's stock in a transaction on Wednesday, June 30th. The shares were sold at an average price of $42.41, for a transaction totalling $212,050.00. Learn More on Scott R. Pancoast's trading history.
Who are DermTech's active insiders?: DermTech's insider roster includes John Dobak (CEO), Claudia Ibarra (COO), Scott Pancoast (Director), Enrico Picozza (Director), Kevin Sun (CFO), and Todd Wood (Insider). Learn More on DermTech's active insiders.
Are insiders buying or selling shares of DermTech?: In the last year, insiders at the sold shares 17 times. They sold a total of 54,064 shares worth more than $110,500.04. The most recent insider tranaction occured on December, 11th when CFO Kevin M Sun sold 447 shares worth more than $648.15. Insiders at DermTech own 5.1% of the company. Learn More about insider trades at DermTech.
Information on this page was last updated on 12/11/2023.

Scott R. Pancoast Insider Trading History at DermTech

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/30/2021	Sell	5,000	$42.41	$212,050.00
12/14/2020	Sell	6,000	$13.93	$83,580.00	44,132
12/7/2020	Sell	2,382	$12.00	$28,584.00	50,132

Scott R. Pancoast Buying and Selling Activity at DermTech

DermTech Company Overview

DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the psoriasis, atopic dermatitis, and aging of the skin to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.

Today's Range

Now: $0.61

$0.60

$0.63

50 Day Range

MA: $0.83

$0.59

$1.36

2 Week Range

Now: $0.61

$0.58

$3.93

Volume

71,612 shs

Average Volume

316,680 shs

Market Capitalization

$21.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.52

Pentagon contract could send this $2 AI stock soaring

From Behind the Markets | Ad

Get all the info here >>>